Johnson & Johnson dividend analysis: Insights from Clemens Faustenhammer 🎯

In this video, Clemens Johnson shares his analysis of Johnson & Johnson, including its transformation, dividend history and strategic positioning. He also discusses classic risks of the pharmaceutical industry, such as patent losses, and gives tips on how to hedge your portfolio with solid investments.

00:00:00 Intro

00:00:15 Johnson & Johnson

00:01:30 Why the spin-off?

00:03:10 Triple A credit rating

00:04:15 Johnson & Johnson for the conservative equity investor?

00:06:20 Dividend yield

00:08:20 Chart analysis

00:10:50 Risk for Johnson & Johnson

00:15:40 Outlook for 2025 by Clemens Faustenhammer

00:17:00 Farewell & Disclaimer

Further links:

CapTrader Homepage: https://www.captrader.com

CapTrader Depot: https://bit.ly/31EqOfE

Demo account with CapTrader: https://bit.ly/3fxv8Fx

CapTrader Newsletter: https://bit.ly/3KNIlpV

--------------------------------------------------------------------------------------

All dates at CapTrader: https://bit.ly/3CGkAgU